跳至主要内容
临床试验/TCTR20230204001
TCTR20230204001已完成1 期

Effects of cannabidiol-enriched cannabis extraction product on cognitive functions and inflammatory markers in Parkinson disease.

Thai Traditional Medical Knowledge Fund0 个研究点目标入组 60 人开始时间: 2023年2月4日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 Years 至 100 Years(—)
性别
All

入选标准

  • The inclusion criteria were age more than 40 years, diagnosis of PD using the UK PD Society Brain Bank diagnostic criteria, Hoehn and Yahr Stages 1 to 3, stable dosage of PD medications for at least 3 months, and willingness of patients and caregivers to participate in the study.

排除标准

  • Patients were excluded if they had dementia, schizophrenia, or other psychotic disorders; kidney or liver disease; serum alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) levels >3 times the upper limit of the normal range; or a history of high-risk behavior related to substance abuse, including nicotine, cannabis, and alcohol.

研究者

发起方
Thai Traditional Medical Knowledge Fund

相似试验